NCT00831714已完成不适用
Xarelto in the Prophylaxis of Post Surgical Venous Thromboembolism After Elective Major Orthopedic Surgery of Hip or Knee
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Bayer
- 入组人数
- 19,076
- 主要终点
- Data collection on: Bleeding events reported as serious or non-serious adverse events; Symptomatic thromboembolic events (DVT, PE) reported as adverse events; Uncommon adverse events (incidence rate between 0.1 % and 1 %); All cause mortality
研究概览
简要总结
The main goal is to provide additional information to the risk-benefit assessment of the drug.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Female and male patients who will undergo elective hip or knee arthroplasty.
排除标准
- •Exclusion criteria must be read in conjunction with the local product information.
研究组 & 干预措施
Group 1
干预措施: Rivaroxaban (Xarelto, BAY59-7939) (Drug)
Group 2
干预措施: Standard care treatment for VTE prophylaxis (Drug)
结局指标
主要结局
Data collection on: Bleeding events reported as serious or non-serious adverse events; Symptomatic thromboembolic events (DVT, PE) reported as adverse events; Uncommon adverse events (incidence rate between 0.1 % and 1 %); All cause mortality
时间窗: During observation period of three months
次要结局
未报告次要终点
研究者
相似试验
撤回
不适用
Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)Prophylaxis, Thromboembolism, VenousTotal Knee ReplacementTotal Hip ReplacementNCT01523418Bayer
已完成
不适用
Study to Gain Information on the Drug Xarelto for the Prevention of Brain Attack and Blockage of an Artery in the Non-central Nervous System Due to Irregular Heartbeat in Taiwanese Patients Suffering From Decreased Renal FunctionNon-valvular Atrial Fibrillation (NVAF)NCT04356989Bayer493
已完成
不适用
Xarelto on Prevention of Stroke and Noncentral Nervous System Systemic Embolism in Treatment-naïve Asian Patients With Non-valvular Atrial FibrillationAtrial FibrillationNCT03284762Bayer1,216
已完成
不适用
Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE)Venous ThromboembolismNCT02558465Bayer2,540
已完成
不适用
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care TherapyDeep Vein ThrombosisVenous ThrombosisNCT01619007Bayer5,145